3 ms·
> Multiple comments here have asked for double blind placebo trials. But you can't really do that with something psycho active, at least not ethically. There a
by PragmaticPulp 6y ago
> Multiple comments here have asked for double blind placebo trials. But you can't really do that with something psycho active, at least not ethically.
There are no ethical barriers to including a control group.
The idea that double-blind, placebo-controlled trials are impossible with psychoactive medication is a strawman argument, because obviously we can still have a control group.
The control group doesn't even need to receive placebo. In a study like this one, they could have easily and ethically had one group receive therapy and a second group receive therapy plus mushrooms. Or the first group could have received therapy plus traditional SSRIs.
The placebo response rate in antidepressant studies is extraordinarily high. There is no good reason to omit a control group in studies like these, other than perhaps if the researchers were too underfunded to make it work.
- LatteLazy 6y agoThe reason you cannot have a double blind study is that you can tell you've been given mushrooms. So, I expect, can the therapist and the researcher etc. The moment anyone knows it's no longer double blind. I'm happy to be corrected if there is some clever way around this. I have heard people suggest you give "control" group members so other psychoactive substance (MDMA was suggested). But that doesn't have the same effect as mushrooms. And also, it's ethically merky to give people other drugs they're not expecting/consenting to. Plus then you don't really have a control group, you have Mushrooms vs Other Drugs...
- tasty_freeze 6y agoPeople have attempted controls in the past, and often it is a high dose of niacin. It causes flushing and increased HR. To someone who has experience with mushrooms they won't be fooled. To someone naive, they can think they got the real deal.
- LatteLazy 6y agoI guess (I'm no expert) we would want a little of both: A blind, Niacin trial that is not placebo controlled AND a Placebo controlled but not blind trial? I wonder what Tim Ferriss has gotten up to recently on this...
- esperent 6y agoBut how can you tell if someone has been fooled or is just saying they've been fooled? When a drug has a very clear and obvious psychoactive effect, double blind simply doesn't work.
- meetups323 6y agoPerhaps at low doses in total darkness?
- raunakdag 6y agoDarkness won’t affect it. You’ll probably be able to tell either way. Microdosing probably wouldn’t make for an effective study, as it’s currently being touted as a way to increase “productivity”.
- austinjp 6y agoIndeed. Other trial designs may also be appropriate such as crossover or waiting lists. Depends on the aims of the study. Double blind RCT simply isn't feasible or appropriate in every circumstance.
- jdietrich 6y ago>waiting lists I'd be careful with that - waiting lists may have a nocebo effect, exaggerating the benefits of the treatment under test. https://onlinelibrary.wiley.com/doi/abs/10.1111/acps.12275 https://onlinelibrary.wiley.com/doi/abs/10.1111/acps.12275
- filoeleven 6y agoYeah, it’s a weird thing to test for. Sort of like trying to double-blind broken bone procedures with a hard cast for the experimental group, and an Ace bandage for placebo. All parties can tell the difference while it’s being applied. Maybe it requires a different kind of experimental structure that still allows for single-blind follow-ups. Imagine the subjects talking a different set of therapists or researchers after 1 month, 3 months, 6 months. The patients/subjects would have to be instructed not to talk about whatever they experienced during the psilocybin/placebo phase, only about their personal development since then: outlook on life, lifestyle changes, etc. The therapists would have to self-invalidate if anything was divulged by a patient. It would probably have to be a large group, since with 1000 people you might only get 300 therapist-blind reports.
- ultimape 6y agoThey're not taking mushrooms, they're taking raw psilosybin sans any of the other active components in the mushrooms such as the bits that act as MAOIs. That seem to help reduce the chance of having a bad experience while tripping. This is why the therapist needs to be involved. If you start seeing demons or negative other hallucinations and can't calm yourself down it can be a traumatic experience.